053950 — Kyung Nam Pharm Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩29bn
- KR₩56bn
- KR₩68bn
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 44,806 | 70,947 | 64,623 | 59,000 | 68,445 |
Cost of Revenue | |||||
Gross Profit | 16,841 | 28,473 | 21,075 | 16,394 | 21,104 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 49,743 | 68,767 | 71,573 | 64,901 | 87,006 |
Operating Profit | -4,937 | 2,180 | -6,949 | -5,900 | -18,560 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6,208 | -7,492 | -3,299 | -7,395 | -21,059 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4,546 | -5,488 | -3,209 | -7,828 | -22,228 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4,546 | -5,488 | -3,413 | -7,828 | -20,997 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -4,546 | -5,488 | -3,413 | -7,828 | -20,997 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -189 | -279 | -173 | -208 | -365 |
Dividends per Share |